Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Fabry Disease Companies

Fabry disease is a rare genetic disorder characterized by the accumulation of a specific type of fat in the body's cells, leading to a range of symptoms that can affect various organs. Companies involved in Fabry disease typically focus on the development of therapies, diagnostic tools, and research initiatives to improve the understanding and management of this rare disorder.

Fabry Disease Key Companies

Latest Fabry Disease Companies Update

January 2024:A Phase 1/2a trial evaluating AMT-191 gene therapy for Fabry disease patients has been cleared by the FDA. This marks a significant step forward in potential curative options for the condition.December 2023:Research suggests that identifying small fiber neuropathy could help with early diagnosis and timely treatment initiation for Fabry patients.October 2023:A study was published identifying a new genetic mutation associated with Fabry disease, potentially paving the way for targeted therapy development.September 2023:Amicus Therapeutics presented positive data from their Phase 3 study on ATG-023 for Fabry patients with neuropathic pain, highlighting potential for additional treatment options.August 2023:Sanofi partnered with the Chordoma Foundation to support research and development efforts for Fabry disease management.

List of Fabry Disease Key Companies in the Market

Amgen Inc.

Amicus Therapeutics Inc.

Bristol-Myers Squibb Company

GlaxoSmithKline

iBio

Neuraltus Pharmaceuticals

Novartis AG

Pfizer Inc.

AVROBIO

Idorsia Pharmaceuticals Ltd

Protalix

Sanofi

Shire

Takeda Pharmaceutical Company Limited

Teva Pharmaceutical Industries Ltd

Fabry Disease Market Highlights:

Fabry Disease Market Size

Fabry Disease Market Trends

Fabry Disease Market Analysis

Fabry Disease Market Share

Fabry Disease Market Highlights:

Fabry Disease Market Trends

Fabry Disease Market Analysis

Fabry Disease Market Share

Fabry Disease Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.